Carmell (NASDAQ:CTCX) Shares Up 6.3%

Carmell Co. (NASDAQ:CTCXGet Free Report)’s stock price was up 6.3% during trading on Tuesday . The company traded as high as $2.45 and last traded at $2.20. Approximately 3,120 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 6,222 shares. The stock had previously closed at $2.07.

Carmell Stock Up 6.3 %

The business’s fifty day moving average price is $2.74 and its 200 day moving average price is $2.95.

Institutional Investors Weigh In On Carmell

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Hubbell Strickland Wealth Management LLC acquired a new position in shares of Carmell during the first quarter worth about $32,000. Linden Advisors LP acquired a new position in Carmell during the third quarter worth about $270,000. Meteora Capital LLC acquired a new position in Carmell during the third quarter worth about $6,416,000. Cookson Peirce & Co. Inc. acquired a new position in Carmell during the third quarter worth about $54,000. Finally, Carnegie Mellon University acquired a new position in Carmell during the third quarter worth about $371,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Further Reading

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.